Evolution of drug therapy for classical Hodgkin lymphoma

Evolution of drug therapy for classical Hodgkin lymphoma

Hodgkin's lymphoma is a malignant disease of the lymphatic system. Hodgkin's lymphoma was first described by Dr. Thomas Hodgkin in 1832 and later named “Hodgkin's disease” by Samuel Wilkes. Hodgkin's lymphoma accounts for about 24 % of all lymphomas. Hodgkin's lymphoma is cl...

Full description

Bibliographic Details
Main Authors: N. Y. Samaneva, I. B. Lysenko, N. V. Nikolaeva, E. A. Kapuza, I. A. Kamaeva, Y. S. Gaysultanova, A. V. Tishina, T. F. Pushkareva
Format: Article
Language:Russian
Published: ANO "Perspective of oncology" 2022-09-01
Series:Южно-Российский онкологический журнал
Subjects:
лимфома ходжкина
вич
вирус эпштейна-барр
игх
ремиссия
прогрессирование
резистентность к химиотерапии
общая выживаемость
Online Access:https://www.cancersp.com/jour/article/view/164

Internet

https://www.cancersp.com/jour/article/view/164

Similar Items